author-photo

Takaaki Tokito

Kurume University

85

Papers

3827

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

Pembrolizumab plus chemotherapy-induced pneumonitis in chemo-naïve patients with non-squamous non-small cell lung cancer: A multicentre, retrospective cohort study.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
MA02.05 A Phase I Study of Afatinib in Combination With Osimertinib in Patients After Failure of Prior Osimertinib

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab Plus Pemetrexed-Platinum for Metastatic Nonsquamous Non-Small-Cell Lung Cancer: KEYNOTE-189 Japan Study.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (2)
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

2021 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (1)
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of atezolizumab for pretreated non-small cell lung cancer with idiopathic interstitial pneumonias.

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study

2020 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (8)
1365P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)